Increased whole body fluid volume status quantified by photon-counting detector CT in patients undergoing TAVR

Background

Before transcatheter aortic valve replacement (TAVR), patients with severe aortic valve stenosis are at an increased risk of developing fluid volume overload and heart failure, which is associated with subsequent adverse outcomes after TAVR.

Purpose

To quantify fluid volume status as whole-body fast-exchange extracellular volume (FE-ECV) in patients undergoing TAVR compared to healthy reference values using photon-counting CT (PCCT).

Methods

Consecutive patients referred for TAVR and healthy living kidney donor candidates, respectively, underwent PCCT including the pelvis. FE-ECV (mL) was quantified using venous hematocrit, injected iodinated contrast concentration and volume, and blood iodine concentration and urinary bladder excreted iodine mass quantified in iodine map regions of interest from the inferior vena cava and covering the urinary bladder, acquired at one time point 6-10 minutes after intravenous iodinated contrast administration.

Results

The study included 156 subjects (healthy: n=51, age 47±9 years, 55% female; TAVR: n=105, age 78±6 years, 39% female). In healthy subjects, FE-ECV was 160±22 mL/kg lean body mass (LBM), 95% limits 116–204 mL/kg LBM, and was independent of age, sex, contrast agent type, and scan delay time after contrast injection (p>0.66 for all). Compared to healthy subjects, FE-ECV in patients referred for TAVR was higher (174±34 mL/kg LBM, p=0.01), with 19 patients (18%) exceeding the normal range.

Conclusion

One in five patients referred for TAVR demonstrated increased FE-ECV, revealing a substantial prevalence of fluid overload detectable by single-time point late-phase PCCT iodine mapping.

Summary statement

PCCT iodine mapping is a simple method enabling objective quantification of whole-body fast-exchange extracellular volume, and revealing increased fluid volume status in patients with severe aortic stenosis undergoing TAVR.

Key Results